Noxopharm Ltd (NOX) Stock Price & News

All values in AUD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	865.44K	865.44K	-151.75K	-151.75K
Cost of goods sold	814.91K	814.91K	156.60K	156.60K
Cost of revenue	814.91K	814.91K	156.60K	156.60K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	694.28K	694.28K	756.98K	756.98K
Operating expense	694.72K	694.72K	757.42K	757.42K
Total operating expenses	1.51M	1.51M	914.02K	914.02K
Operating income	-644.20K	-644.20K	-1.07M	-1.07M
Other non operating income	-19.92K	-19.92K	-144.08K	-144.08K
EBT including unusual items	-920.72K	-920.72K	-1.31M	-1.31M
EBT excluding unusual items	-920.72K	-920.72K	-1.52M	-1.52M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-920.72K	-920.72K	-1.31M	-1.31M
Net profit margin	-106.39%	-106.39%	861.44%	861.44%
Earnings per share	-	-	-	-
Interest and investment income	1.70K	1.70K	9.26K	9.26K
Interest expense	-250.29K	-250.29K	-329.48K	-329.48K
Net interest expenses	-248.58K	-248.58K	-320.22K	-320.22K
Depreciation and amortization charges	440.00	440.00	432.00	432.00
EBITDA	-643.76K	-643.76K	-1.07M	-1.07M
Gain or loss from assets sale	-	-	-	-

Finance